Q: Hi 5i,
How do you feel about Aurinia, hey will be cashflow positive soon. Recently they announced a 150 million buy back with a 25% staff reduction. They are also ending a strategic review. Sales are ramping up looks like a timely buy with share price at a low. Your thoughts are appreciated.
How do you feel about Aurinia, hey will be cashflow positive soon. Recently they announced a 150 million buy back with a 25% staff reduction. They are also ending a strategic review. Sales are ramping up looks like a timely buy with share price at a low. Your thoughts are appreciated.
Q: Hi 5i, this company recently tried to sell itself and there were no takers. They now have decided to let go of 25% of the workforce and buy up to 150 million dollars of shares back.
Looks like they will be cash flow positive by next quarter and are starting to get better traction on selling the drug.
The drug patent is for dosing as the chemical composition expires in a couple years. How would you value this company and would you rate it a buy hold or sell.
Looks like they will be cash flow positive by next quarter and are starting to get better traction on selling the drug.
The drug patent is for dosing as the chemical composition expires in a couple years. How would you value this company and would you rate it a buy hold or sell.
Q: Aurinia Pharmaceuticals will become self sustaining most likely next quarter, they have had two revenue upgrades in a row! But share price does not appear to reflect this. Shareholders are putting managements feet to the fire looking for alignment to creating value for investors.
What do you folks think is this one ever going to launch?
What do you folks think is this one ever going to launch?